Literature DB >> 18685494

Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays.

Linda Paavilainen1, Henrik Wernérus, Peter Nilsson, Mathias Uhlén, Sophia Hober, Kenneth Wester, Fredrik Pontén.   

Abstract

Generation of monospecific antibodies (msAbs) (multiepitope) through affinity purification of polyclonal antisera is a plausible strategy for high-throughput production of affinity reagents toward large sets of proteins. These antibodies are generated using readily accessible gene sequence information from publicly available databases. The resulting antibodies have the potential to be used in a variety of assays, probing differentially presented and altered proteins with high sensitivity and specificity. In the present study, 48 msAbs were compared with corresponding commercial analogs. Immunohistochemical staining properties were evaluated on tissue microarrays, representing various normal human tissues from 144 different individuals. MsAbs showed similar immunostaining patterns as compared with corresponding commercial analogs in 44 out of totally 48 (92%) antibody pairs analyzed. Although only few antibody pairs showed major discrepancies, minor dissimilarities were frequently seen. Our results suggest that msAbs are reliable and valuable tools in antibody-based proteomics, enabling analysis of protein expression patterns in cells and tissues. High-throughput strategies employing such antibodies provide a consistent approach in the exploration of the human proteome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685494     DOI: 10.1097/PAI.0b013e31817c645e

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

1.  Proximity Ligation Assay as a Tool for Antibody Validation in Human Tissues.

Authors:  Cecilia Lindskog; Max Backman; Agata Zieba; Anna Asplund; Mathias Uhlén; Ulf Landegren; Fredrik Pontén
Journal:  J Histochem Cytochem       Date:  2020-06-30       Impact factor: 2.479

2.  Tissue profiling of the mammalian central nervous system using human antibody-based proteomics.

Authors:  Jan Mulder; Erik Björling; Kalle Jonasson; Henrik Wernérus; Sophia Hober; Tomas Hökfelt; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

3.  Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics.

Authors:  Chen Fei; Christina Atterby; Per-Henrik Edqvist; Fredrik Pontén; Wei Wei Zhang; Erik Larsson; Frank P Ryan
Journal:  J R Soc Med       Date:  2013-11-21       Impact factor: 5.344

4.  Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas.

Authors:  Caroline Kampf; Ingmarie Olsson; Urban Ryberg; Evelina Sjöstedt; Fredrik Pontén
Journal:  J Vis Exp       Date:  2012-05-31       Impact factor: 1.355

5.  GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome.

Authors:  Anja Smits; Zhe Jin; Tamador Elsir; Hugo Pedder; Monica Nistér; Irina Alafuzoff; Anna Dimberg; Per-Henrik Edqvist; Fredrik Pontén; Eleonora Aronica; Bryndis Birnir
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

6.  Antibodies biotinylated using a synthetic Z-domain from protein A provide stringent in situ protein detection.

Authors:  Sandra Andersson; Anna Konrad; Nikhil Ashok; Fredrik Pontén; Sophia Hober; Anna Asplund
Journal:  J Histochem Cytochem       Date:  2013-08-06       Impact factor: 2.479

7.  PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.

Authors:  Kenney R Roodakker; Tamador Elsir; Per-Henrik D Edqvist; Daniel Hägerstrand; Joseph Carlson; Malgorzata Lysiak; Roger Henriksson; Fredrik Pontén; Johan Rosell; Peter Söderkvist; Roger Stupp; Elena Tchougounova; Monica Nistér; Annika Malmström; Anja Smits
Journal:  Oncotarget       Date:  2016-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.